|
|
|
Insider
Information: |
Bradsher Neal C |
Relationship: |
10% Owner |
City: |
Union City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
129,185 |
|
Indirect Shares
|
57,363,752 |
|
|
Direct
Value |
$1,186,888 |
|
|
Indirect Value
|
$499,113,789 |
|
|
Total
Shares |
57,492,937 |
|
|
Total
Value |
$500,300,677 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
60
|
50
|
Stock
price went up :
|
44
|
16
|
Stock
price went down : |
16
|
34
|
|
|
|
Gain/Loss Ratio : |
2.8
|
2.8
|
Percentage
Gain/Loss : |
10.9%
|
-929.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Questcor Pharmaceuticals Inc |
QCOR |
Director |
2014-08-14 |
0 |
2014-08-14 |
0 |
Premium* |
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director, 10% Owner |
2024-02-06 |
87,628 |
2024-02-06 |
41,666,255 |
Premium* |
|
Comarco Inc |
CMRO |
10% Owner |
2017-09-15 |
15,500 |
2017-09-15 |
0 |
Premium* |
|
STAAR Surgical Co |
STAA |
10% Owner |
2024-05-09 |
25,900 |
2024-05-09 |
10,768,431 |
Premium* |
|
Palomar Medical Technologies Inc |
PMTI |
10% Owner |
2013-06-24 |
0 |
2013-06-24 |
0 |
Premium* |
|
Asterias Biotherapeutics Inc |
AST |
See Remarks Below |
2019-03-08 |
0 |
2019-03-08 |
0 |
Premium* |
|
Oncocyte Corp |
OCX |
10% Owner |
2024-04-11 |
157 |
2024-04-11 |
4,929,066 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AST |
Asterias Biotherapeutics ... |
See Remarks Section |
|
2015-02-10 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
641,025 |
0 |
- |
|
AST |
Asterias Biotherapeutics ... |
See Remarks Section |
|
2015-02-10 |
4 |
A |
$3.90 |
$2,499,998 |
D/D |
641,025 |
641,025 |
0 |
- |
|
AST |
Asterias Biotherapeutics ... |
See Remarks Section |
|
2015-05-21 |
4 |
OE |
$2.34 |
$2,340,000 |
D/D |
1,000,000 |
1,641,025 |
0 |
- |
|
AST |
Asterias Biotherapeutics ... |
See Remarks Section |
|
2015-05-21 |
4 |
OE |
$0.00 |
$0 |
I/I |
0 |
1,641,025 |
0 |
- |
|
AST |
Asterias Biotherapeutics ... |
See Remarks Section |
|
2017-10-16 |
4 |
B |
$2.60 |
$4,140,001 |
D/D |
1,592,308 |
5,292,156 |
2.44 |
- |
|
AST |
Asterias Biotherapeutics ... |
See Remarks Section |
|
2017-10-16 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
5,292,156 |
0.01 |
- |
|
AST |
Asterias Biotherapeutics ... |
See Remarks Below |
|
2019-03-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(0) |
0 |
0 |
- |
|
AST |
Asterias Biotherapeutics ... |
See Remarks Below |
|
2019-03-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,292,156) |
0 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
officerTitle |
|
2005-12-29 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
1,911,078 |
|
- |
|
LCTX |
Lineage Cell Therapeutics... |
officerTitle |
|
2005-12-29 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
1,868,170 |
|
- |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2004-03-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,182,160 |
|
- |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2005-11-01 |
4 |
B |
$0.80 |
$329,199 |
I/I |
413,100 |
2,595,260 |
2.1 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2005-11-02 |
4 |
B |
$0.80 |
$98,135 |
I/I |
123,100 |
2,718,360 |
2.1 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2006-05-12 |
4/A |
B |
$1.67 |
$166,570 |
I/I |
100,000 |
2,818,360 |
2.1 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2006-05-12 |
4 |
A |
$1.67 |
$166,570 |
I/I |
100,000 |
2,818,360 |
|
- |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2006-05-15 |
4/A |
B |
$1.51 |
$203,405 |
I/I |
135,000 |
2,953,360 |
2.1 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2006-05-15 |
4 |
A |
$1.51 |
$203,405 |
I/I |
135,000 |
2,953,360 |
|
- |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2006-12-13 |
4 |
B |
$1.45 |
$290,000 |
I/I |
200,000 |
3,153,360 |
2.1 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2007-03-15 |
4 |
B |
$0.75 |
$323,436 |
I/I |
425,300 |
3,578,660 |
2.1 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2009-07-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,100,000 |
4,031,153 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2009-07-10 |
4 |
OE |
$0.00 |
$0 |
I/I |
0 |
4,031,153 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2012-11-15 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
8,622,220 |
2.17 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2012-11-15 |
4 |
B |
$2.90 |
$1,000,001 |
D/D |
344,828 |
8,622,220 |
3.92 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2013-03-28 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
8,822,220 |
2.17 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2013-03-28 |
4 |
B |
$3.81 |
$762,000 |
D/D |
200,000 |
8,822,220 |
3.92 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|